Related Experiment Videos
Reverse transcriptase inhibitors and chemically induced bladder tumors in mice.
Investigative Urology
|March 1, 1977
Summary
Oncogenic viruses may contribute to bladder cancer. Antiviral drugs targeting reverse transcriptase did not prevent tumors, suggesting viral reproduction isn't essential for malignant transformation.
Area of Science:
- Oncology
- Virology
- Carcinogenesis
Background:
- Urothelial tumors (bladder cancer) may be linked to specific oncogenic viruses.
- These viruses might act with chemical carcinogens to promote cancer.
- Viral reverse transcriptase enables genetic incorporation into host cells, allowing vertical transmission.
Purpose of the Study:
- To investigate the role of viral reverse transcriptase in chemical carcinogen-induced bladder tumors.
- To determine if inhibiting reverse transcriptase affects bladder tumor development.
Main Methods:
- Mice (C3H) were administered a chemical carcinogen, 2-formylamino-4-(5-nitro-2-furyl) thiazole (FANFT).
- Specific antiviral agents (dimethylbenzyldemethl-rifampicin and streptovaricin-comples) targeting reverse transcriptase were administered.
- Tumor induction rates and timing were monitored.
Main Results:
- Inhibition of reverse transcriptase did not delay the induction of bladder tumors by FANFT.
- Viral reproduction and release were not essential for malignant transformation in this model.
Conclusions:
- While viral reproduction may not be critical, inherited viral genetic information could still play a role in bladder cancer oncogenesis.
- Further research is needed to explore the potential involvement of latent viral genetic material in urothelial tumor development.